Sofosbuvir and simeprevir is effective for recurrent hepatitis C in liver transplant recipients. [electronic resource]
Producer: 20160801Description: 2442-7 p. digitalISSN:- 1478-3231
- Aged
- Antiviral Agents -- adverse effects
- Drug Therapy, Combination
- Female
- Hepacivirus
- Hepatitis C, Chronic -- drug therapy
- Humans
- Liver Transplantation
- Male
- Middle Aged
- RNA, Viral -- blood
- Recurrence
- Regression Analysis
- Retrospective Studies
- Simeprevir -- adverse effects
- Sofosbuvir -- adverse effects
- Transplant Recipients
- Treatment Outcome
- Viral Load
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.